Antonio
Domínguez Meijide
Max Planck Institute for Experimental Medicine
Gotinga, AlemaniaPublicacións en colaboración con investigadores/as de Max Planck Institute for Experimental Medicine (11)
2024
2022
-
Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells
Molecular Neurobiology, Vol. 59, Núm. 2, pp. 1273-1284
2021
-
Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity
Frontiers in Aging Neuroscience, Vol. 13
-
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo
Neurobiology of Disease, Vol. 151
2020
-
Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
Scientific Reports, Vol. 10, Núm. 1
-
Pharmacological modulators of tau aggregation and spreading
Brain Sciences, Vol. 10, Núm. 11, pp. 1-29
-
Synucleinopathies: Where we are and where we need to go
Journal of Neurochemistry, Vol. 153, Núm. 4, pp. 433-454
2019
-
Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies
Cell Reports, Vol. 28, Núm. 1, pp. 65-77.e6
-
LRRK2, alpha-synuclein, and tau: Partners in crime or unfortunate bystanders?
Biochemical Society Transactions, Vol. 47, Núm. 3, pp. 827-838
-
Spreading of α-synuclein and tau: A systematic comparison of the mechanisms involved
Frontiers in Molecular Neuroscience, Vol. 12
-
Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding
Bioorganic and Medicinal Chemistry, Vol. 27, Núm. 1, pp. 79-91